Abstract:OBJECTIVES:Basal forebrain cholinergic neurons are proposed as a major neuromodulatory system in inflammatory modulation. However, the function of basal forebrain cholinergic neurons in sepsis is unknown, and the neural pathways underlying cholinergic anti-inflammation remain unexplored.DESIGN:Animal research.SETTING:University research laboratory.SUBJECTS:Male wild-type C57BL/6 mice and ChAT-ChR2-EYFP (ChAT) transgenic mice.INTERVENTIONS:The cholinergic neuronal activity of the basal forebrain was manipulated optogenetically. Cecal ligation and puncture was produced to induce sepsis. Left cervical vagotomy and 6-hydroxydopamine injection to the spleen were used.MEASUREMENTS AND MAIN RESULTS:Photostimulation of basal forebrain cholinergic neurons induced a significant decrease in the levels of tumor necrosis factor-α and interleukin-6 in the serum and spleen. When cecal ligation and puncture was combined with left cervical vagotomy in photostimulated ChAT mice, these reductions in tumor necrosis factor-α and interleukin-6 were partly reversed. Furthermore, photostimulating basal forebrain cholinergic neurons induced a large increase in c-Fos expression in the basal forebrain, the dorsal motor nucleus of the vagus, and the ventral part of the solitary nucleus. Among them, 35.2% were tyrosine hydroxylase positive neurons. Furthermore, chemical denervation showed that dopaminergic neurotransmission to the spleen is indispensable for the anti-inflammation.CONCLUSIONS:These results are the first to demonstrate that selectively activating basal forebrain cholinergic neurons is sufficient to attenuate systemic inflammation in sepsis. Specifically, photostimulation of basal forebrain cholinergic neurons activated dopaminergic neurons in dorsal motor nucleus of the vagus/ventral part of the solitary nucleus, and this dopaminergic efferent signal was further transmitted by the vagus nerve to the spleen. This cholinergic-to-dopaminergic neural circuitry, connecting central cholinergic neurons to the peripheral organ, might have mediated the anti-inflammatory effect in sepsis.

Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis

Early Antagonism of Cerebral High Mobility Group Box-1 Protein is Benefit for Sepsis Induced Brain Injury.

Inhibition of Cerebral High-Mobility Group Box 1 Protein Attenuates Multiple Organ Damage and Improves T Cell-Mediated Immunity in Septic Rats

Deficiency of the Novel High Mobility Group Protein HMGXB4 Protects Against Systemic Inflammation-Induced Endotoxemia in Mice.

High Mobility Group Protein 1 Reverses Immune System Paralysis in Late-Phase Sepsis

Novel Insights For High Mobility Group Box 1 Protein-Mediated Cellular Immune Response In Sepsis: A Systemic Review

High-mobility Group Box 1 Mediates Persistent Splenocyte Priming in Sepsis Survivors: Evidence from a Murine Model.

Antagonism of Integrin CD11b Affords Protection Against Endotoxin Shock and Polymicrobial Sepsis Via Attenuation of HMGB1 Nucleocytoplasmic Translocation and Extracellular Release.

HMGB1 Mediates Synaptic Loss and Cognitive Impairment in an Animal Model of Sepsis-Associated Encephalopathy

The Effect of High Mobility Group Box-1 Protein on Splenic Dendritic Cell Maturation in Rats.

Inflammatory Response and Immune Regulation of High Mobility Group Box-1 Protein in Treatment of Sepsis.

Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes

Selective Activation of Basal Forebrain Cholinergic Neurons Attenuates Polymicrobial Sepsis–Induced Inflammation Via the Cholinergic Anti-Inflammatory Pathway

The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

Sphingosine 1-Phosphate Receptor-3 Contributes to Host Defense Against Polymicrobial Sepsis Via Modulating Macrophage Chemotaxis (CAM4P.161)

Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury

Therapeutic Potential of HMGB1-targeting Agents in Sepsis.

Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway

Severity of Sepsis is Correlated with the Elevation of Serum High-Mobility Group Box 1 in Rats.

HMGB1 Mediates Splenomegaly, Anemia and Leukocytosis in Mice Surviving Sepsis (44.7)